Risperdal Problems for J&J Highlighted By $70M Verdict

Harvey Kirk

By Harvey Kirk
Posted July 5, 2016


While Johnson & Johnson has continued to refuse to settle Risperdal lawsuits being pursued by hundreds of boys and young men who developed gynecomastia after using their popular medication, a Pennsylvania jury sent a resounding message last week, awarding $70 million in damages in one case.

The verdict highlights the extent of the Risperdal problems and potential liability Johnson & Johnson faces as a result of the drug maker’s decision not to warn about the gynecomastia risk.

The bellwether award came in a case filed by the family of five year old boy who developed breast after being prescribed Risperdal. While the verdict is the largest issued by a jury to date, it is the latest in a series of high jury awards returned in test cases that have gone to trial so far.

Risperdal Breast Growth Problems

Did You or Your Son Experience Risperdal Breast Growth Problems?


While the outcomes of these early trial dates is not binding on other claims, they are being closely watched, as they may gauge how juries will respond to certain evidence and testimony that is likely to be repeated throughout hundreds of cases pending on behalf of boys and young men nationwide.

According to evidence presented at trial, Johnson & Johnson has known, or should have known, about the link between Risperdal and breat growth among young boys, yet withheld that information from consumers and the medical community.

The large verdict awarded in this one case highlights the severe impact Risperdal breast growth may cause, including the need for surgical breast removal and severe psychological damage.

Johnson & Johnson has indicated that the verdict is excessive and that it intends to appeal, but it is likely a number of other reasonable juries may view the evidence the same way in similar cases, highlighting the extent of liability the company may face if fair Risperdal settlements are not offered to resolve the litigation.

While cases continue to move toward trial nationwide, our Risperdal injury lawyers at Saiontz & Kirk, P.A. continue to review and file cases for young men and families of boys diagnosed with gynecomastia.

All lawsuits are being pursued by our law firm under a contingency fee agreement, which means that there are no out-of-pocket costs to hire our lawyers and there are no attorney fees or expenses unless a recovery is obtained.


No Comments • Add Your Comments

Add Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide contact information below and additional private comments if you want an attorney to contact you to review a potential case.

    The information below will not be published to this page.

  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.